Goutham Sunny
@medoncodoc
Academic account. Oncology & #medtwitter. Passionate about Preventive & community oncology, Big data, Computational onco and AI, Health economics, Med-Ed.
ID: 99938573
28-12-2009 12:37:39
2,2K Tweet
424 Followers
597 Following
ECHO trial out! Addition of Acalabrutinib to RB in untreated MCL lead to PFS benefit with similar toxicity. No OS benefit 𝗡𝗶𝗵𝗮𝗿 𝗗𝗲𝘀𝗮𝗶 MD, DM Mithun Abraham Prakash Vishvdeep Khushoo akhilrk1989 Dr Akhil Santhosh doi.org/10.1200/JCO-25…
